Business

Announcement on Voluntary Disclosure of HER2 Gene Detection Kit (Fluorescence in Situ Hybridization) Obtaining Registration Approval for Medical Device Changes

Announcement on Voluntary Disclosure of HER2 Gene Detection Kit (Fluorescence in Situ Hybridization) Obtaining Registration Approval for Medical Device Changes

articleGuangzhou Lbp Medicine Science & Technology Co., Ltd. Class ADecember 31, 20245/news/announcement-on-voluntary-disclosure-of-her2-gene-detection-kit-fluorescence-in-situ-hybridization-obtaining-registration-approval-for-medical-device-changes
Announcement on Voluntary Disclosure of HER2 Gene Detection Kit (Fluorescence in Situ Hybridization) Obtaining Registration Approval for Medical Device Changes

About this update from Guangzhou Lbp Medicine Science & Technology Co., Ltd. Class A

Announcement on Voluntary Disclosure of HER2 Gene Detection Kit (Fluorescence in Situ Hybridization) Obtaining Registration Approval for Medical Device ChangesThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Guangzhou Lbp Medicine Science & Technology Co., Ltd. Class A